Feb. 27, 2024 at 10:55 a.m. ET
Two companies dominate the weight-loss drug market, but new competitors are entering the two-horse race. Maurits Pot, CEO of Tema ETF, explains what investors should know about the strategy and challenges of different players in the field.
Read the full article here